December 4, 2024 | Béla Merkely and C. Michael Gibson discuss the results of a CRT-D upgrade versus ICD alone for HFrEF patients with right ventricular pacing. Receive the the latest news, research, ...

The ASX healthcare sector finished the week in a steady state, despite ripple effects of a sharp sell-off on Wall Street.

The global pacemakers market is on track to witness steady growth, projected at a rate of 3-4% annually by 2028. This expansion is fueled by a confluence of factors, from the growing burden of ...

近日， 长沙市望城区人民医院心血管内科二病区 成功为一名80岁高龄的主动脉瓣重度狭窄患者实施经导管主动脉瓣置换术（TAVR），术后患者不适症状明显改善，生活质量大幅提升。

Special Report: Fresh clinical studies suggest EBR Systems’ WiSE left ventricular pacing device could have two additional, as-yet unapproved clinical applications beyond its core use in cardiac ...

One application pairs WiSE with a leadless pacemaker to deliver leadless LBBAP/CSP The other involves using WiSE to deliverCRT as a second-line option Special Report: Fresh clinical studies suggest ...

对于广大房颤患者而言，上海交通大学医学院附属第九人民医院内FARAPULSE™脉冲电场消融术的落地，意味着在治疗道路上多了一个更优的选择。其更短的手术时间、更高的安全性和“一击即中”的精准性，极大地减轻了患者的身心负担。未来，上海交通大学医学院附属第九人民医院将继续积累病例经验，不断优化治疗流程，力求用最前沿的医疗科技为每一位房颤患者提供最个体化、最前沿、最有效的治疗方案。

Two new studies outline new clinical applications for WiSE cardiac pacing device One application pairs WiSE with a leadless pacemaker to deliver leadless LBBAP/CSP The other involves using WiSE to ...